Your browser doesn't support javascript.
loading
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
Ortíz-Maldonado, Valentín; Rives, Susana; Castellà, Maria; Alonso-Saladrigues, Anna; Benítez-Ribas, Daniel; Caballero-Baños, Miguel; Baumann, Tycho; Cid, Joan; Garcia-Rey, Enric; Llanos, Cristina; Torrebadell, Montserrat; Villamor, Neus; Giné, Eva; Díaz-Beyá, Marina; Guardia, Laia; Montoro, Mercedes; Català, Albert; Faura, Anna; González, E Azucena; Español-Rego, Marta; Klein-González, Nela; Alsina, Laia; Castro, Pedro; Jordan, Iolanda; Fernández, Sara; Ramos, Federico; Suñé, Guillermo; Perpiñá, Unai; Canals, Josep M; Lozano, Miquel; Trias, Esteve; Scalise, Andrea; Varea, Sara; Sáez-Peñataro, Joaquín; Torres, Ferran; Calvo, Gonzalo; Esteve, Jordi; Urbano-Ispizua, Álvaro; Juan, Manel; Delgado, Julio.
  • Ortíz-Maldonado V; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Rives S; Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.
  • Castellà M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.
  • Alonso-Saladrigues A; Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Benítez-Ribas D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Caballero-Baños M; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Baumann T; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.
  • Cid J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Apheresis & Cell Therapy Unit, Department of Hemotherapy and Hemostasis, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Garcia-Rey E; Banc de Sang i Teixits, Barcelona, Spain.
  • Llanos C; Clinical Research Unit, Fundació Sant Joan de Déu, Barcelona, Spain.
  • Torrebadell M; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain; Laboratory of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) , Barcelona, Spain.
  • Villamor N; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Giné E; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Díaz-Beyá M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.
  • Guardia L; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Montoro M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Català A; Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.
  • Faura A; Department of Hematology/Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • González EA; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Español-Rego M; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Klein-González N; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Alsina L; Clinical Immunology Platform Clínic-Sant Joan de Déu, Barcelona, Spain.
  • Castro P; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
  • Jordan I; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain; University of Barcelona, Barcelona, Spain; Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Fernández S; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Ramos F; Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Suñé G; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain.
  • Perpiñá U; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain.
  • Canals JM; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedicine, Production and Validation Center of Advanced Therapies (Creatio), University of Barcelona, Barcelona, Spain.
  • Lozano M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Apheresis & Cell Therapy Unit, Department of Hemotherapy and Hemostasis, Hospital Clínic de Barcelona, Barcelona, Spain; University of Barcelona, Barcelona, Spain.
  • Trias E; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Scalise A; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Varea S; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Sáez-Peñataro J; University of Barcelona, Barcelona, Spain; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Torres F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Calvo G; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain; Department of Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Esteve J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; University of Barcelona, Barcelona, Spain; Institute of Research Josep Carreras, Barcelona, Spain.
  • Urbano-Ispizua Á; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; University of Barcelona, Barcelona, Spain; Institute of Research Josep Carreras, Barcelona, Spain.
  • Juan M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain; Clinical Immunology Platform Clínic-Sant Joan de Déu, Barcelona, Spain; University of Barcelona, Barcelona, Spain; Advanced Therapies Unit,
  • Delgado J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain; University of Barcelona, Barcelona, Spain. Electronic addr
Mol Ther ; 29(2): 636-644, 2021 02 03.
Article en En | MEDLINE | ID: mdl-33010231
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Antígenos CD19 / Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Antígenos CD19 / Receptores Quiméricos de Antígenos / Neoplasias Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article